We used The National Cancer Institute GDC data portal and Genotype-Tissue Expression (GTEx) (v8) project database and compared CD29 expression levels on stages I, II, III, and IV melanoma, bladder, and lymphoma cancer cells samples (Figures 7A–C, respectively). This evidence concerns the gene ITGB1 and melanoma.